Viking Therapeutics, Inc. (VKTX)
32.28
+0.97
(+3.10%)
USD |
NASDAQ |
May 06, 16:00
32.06
-0.22
(-0.68%)
After-Hours: 07:36
Viking Therapeutics Cash from Investing (Quarterly) : 54.19M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -3.916B |
| Amgen, Inc. | -716.00M |
| Hims & Hers Health, Inc. | -83.68M |
| Structure Therapeutics, Inc. | 56.31M |
| Pfizer Inc. | 785.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -113.98M |
| Cash from Financing (Quarterly) | 12.08M |
| Free Cash Flow | -340.33M |
| Free Cash Flow Per Share (Quarterly) | -0.9862 |
| Free Cash Flow to Equity (Quarterly) | -113.84M |
| Free Cash Flow to Firm (Quarterly) | -113.98M |
| Free Cash Flow Yield | -9.29% |